Relationships between serum MCP-1 and subclinical kidney disease: African American-Diabetes Heart Study

[1]  J. Navarro-González,et al.  Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy , 2011, Nature Reviews Nephrology.

[2]  Joon-Young Park,et al.  Racial Differences in Oxidative Stress and Inflammation: In Vitro and In Vivo , 2011, Clinical and Translational Science.

[3]  C. Lewis,et al.  Correlates of coronary artery calcified plaque in blacks and whites with type 2 diabetes. , 2011, Annals of epidemiology.

[4]  S. Tonstad,et al.  Determinants of inflammatory markers in a bi-ethnic population. , 2011, Ethnicity & disease.

[5]  M. Wurfel,et al.  MCP-1 gene activation marks acute kidney injury. , 2011, Journal of the American Society of Nephrology : JASN.

[6]  Hyoung-Kyu kim,et al.  CCR2 antagonism improves insulin resistance, lipid metabolism, and diabetic nephropathy in type 2 diabetic mice. , 2010, Kidney international.

[7]  D. Greaves,et al.  Inflammatory cell recruitment in cardiovascular disease: murine models and potential clinical applications. , 2010, Clinical science.

[8]  C. Schmid,et al.  A new equation to estimate glomerular filtration rate. , 2009, Annals of internal medicine.

[9]  K. Ley,et al.  Immune and inflammatory mechanisms of atherosclerosis (*). , 2009, Annual review of immunology.

[10]  Z. Sui,et al.  Recent developments in CCR2 antagonists , 2009, Expert opinion on therapeutic patents.

[11]  N. Frangogiannis,et al.  Monocyte chemoattractant protein-1/CCL2 as a biomarker in acute coronary syndromes , 2009, Current atherosclerosis reports.

[12]  A. Krolewski,et al.  Serum concentrations of markers of TNFalpha and Fas-mediated pathways and renal function in nonproteinuric patients with type 1 diabetes. , 2009, American Society of Nephrology. Clinical Journal.

[13]  G. Tesch.  MCP-1/CCL2: a new diagnostic marker and therapeutic target for progressive renal injury in diabetic nephropathy. , 2008, American journal of physiology. Renal physiology.

[14]  A. Krolewski,et al.  Association of urinary inflammatory markers and renal decline in microalbuminuric type 1 diabetics. , 2008, Journal of the American Society of Nephrology : JASN.

[15]  J. Eckel,et al.  Monocyte chemotactic protein-1 and its role in insulin resistance , 2007, Current opinion in lipidology.

[16]  J. Chan,et al.  Aberrant activation profile of cytokines and mitogen‐activated protein kinases in type 2 diabetic patients with nephropathy , 2007, Clinical and experimental immunology.

[17]  A. Folsom,et al.  Absolute and attributable risks of cardiovascular disease incidence in relation to optimal and borderline risk factors: comparison of African American with white subjects--Atherosclerosis Risk in Communities Study. , 2007, Archives of internal medicine.

[18]  R. Atkins,et al.  Macrophage accumulation in human progressive diabetic nephropathy , 2006, Nephrology.

[19]  B. Kestenbaum,et al.  Racial and ethnic differences in incident myocardial infarction in end-stage renal disease patients: The USRDS. , 2006, Kidney international.

[20]  R. Atkins,et al.  Monocyte chemoattractant protein-1 promotes the development of diabetic renal injury in streptozotocin-treated mice. , 2006, Kidney international.

[21]  F. Hsu,et al.  The impact of ethnicity and sex on subclinical cardiovascular disease: the Diabetes Heart Study , 2005, Diabetologia.

[22]  D. Levy,et al.  Low-Grade Albuminuria and Incidence of Cardiovascular Disease Events in Nonhypertensive and Nondiabetic Individuals: The Framingham Heart Study , 2005, Circulation.

[23]  K. Lohman,et al.  Relationship between albuminuria and cardiovascular disease in Type 2 diabetes. , 2005, Journal of the American Society of Nephrology : JASN.

[24]  R. Detrano,et al.  Ethnic Differences in Coronary Calcification: The Multi-Ethnic Study of Atherosclerosis (MESA) , 2005, Circulation.

[25]  R. Blair,et al.  Effects of soy isoflavones and conjugated equine estrogens on inflammatory markers in atherosclerotic, ovariectomized monkeys. , 2005, The Journal of clinical endocrinology and metabolism.

[26]  A. Khera,et al.  Association among plasma levels of monocyte chemoattractant protein-1, traditional cardiovascular risk factors, and subclinical atherosclerosis. , 2004, Journal of the American College of Cardiology.

[27]  D. Loskutoff,et al.  Monocyte chemoattractant protein 1 in obesity and insulin resistance , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[28]  E. Antman,et al.  Association Between Plasma Levels of Monocyte Chemoattractant Protein-1 and Long-Term Clinical Outcomes in Patients With Acute Coronary Syndromes , 2003, Circulation.

[29]  M. Kakei,et al.  Association of monocyte chemoattractant protein-1 with renal tubular damage in diabetic nephropathy. , 2003, Journal of diabetes and its complications.

[30]  Jennifer Y. Liu,et al.  Ethnic disparities in diabetic complications in an insured population. , 2002, JAMA.

[31]  Tom Greene,et al.  Calibration and random variation of the serum creatinine assay as critical elements of using equations to estimate glomerular filtration rate. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[32]  S. Yusuf,et al.  Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. , 2001, JAMA.

[33]  B. Pannier,et al.  Creatinine clearance, pulse wave velocity, carotid compliance and essential hypertension. , 2001, Kidney international.

[34]  C. Langefeld,et al.  Familial aggregation of coronary artery calcium in families with type 2 diabetes. , 2001, Diabetes.

[35]  G. Remuzzi,et al.  Nephropathy of type 1 and type 2 diabetes: diverse pathophysiology, same treatment? , 2000, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[36]  K. Matsushima,et al.  Up-regulation of monocyte chemoattractant protein-1 in tubulointerstitial lesions of human diabetic nephropathy. , 2000, Kidney international.

[37]  P. Stenvinkel,et al.  Elevated serum levels of soluble adhesion molecules predict death in pre-dialysis patients: association with malnutrition, inflammation, and cardiovascular disease. , 2000, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[38]  Y. Hattori,et al.  Possible relationship of monocyte chemoattractant protein-1 with diabetic nephropathy. , 2000, Kidney international.

[39]  P. Stenvinkel,et al.  Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. , 1999, Kidney international.

[40]  A. Levey,et al.  A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation , 1999, Annals of Internal Medicine.

[41]  B. Rollins,et al.  MCP-1 deficiency reduces susceptibility to atherosclerosis in mice that overexpress human apolipoprotein B. , 1999, The Journal of clinical investigation.

[42]  K. Matsushima,et al.  Urinary levels of chemokines (MCAF/MCP‐1, IL‐8) reflect distinct disease activities and phases of human IgA nephropathy , 1998, Journal of leukocyte biology.

[43]  A. Matsumori,et al.  Plasma levels of the monocyte chemotactic and activating factor/monocyte chemoattractant protein-1 are elevated in patients with acute myocardial infarction. , 1997, Journal of molecular and cellular cardiology.

[44]  B. Rovin,et al.  Monocyte chemoattractant protein-1 levels in patients with glomerular disease. , 1996, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[45]  K. Matsushima,et al.  Monitoring urinary levels of monocyte chemotactic and activating factor reflects disease activity of lupus nephritis. , 1996, Kidney international.

[46]  C. Alpers,et al.  Cellular events in the evolution of experimental diabetic nephropathy. , 1995, Kidney international.

[47]  F. Mosteller,et al.  Low Moments for Small Samples: A Comparative Study of Order Statistics , 1947 .